Welcome to Pipeline Review

Generex Biotechnology, and their wholly owned subsidiary Antigen Express, are developing promising new drugs to treat diabetes, as well as synthetic peptide vaccines targeting HER2/neu cancer and pandemic flu. The flagship product for Generex is Oral-lyn buccal insulin. Antigen Express' leading vaccine is the AE37 HER2/neu synthetic peptide vaccine to prevent breast cancer recurrence. I am not qualified to offer investment or medical advice, and make no claims that I am an expert in these areas. I am a layman and a shareholder in this company. The left side of Pipeline Review holds blogs regarding Generex and Antigen Express, while the right side offers items of due diligence mixed with my analysis which may be of interest to others seeking to learn about Generex's pipeline. If the left side only shows the latest blog, click on the word home to view them all.

Search This Blog

Tuesday, March 13, 2012

Antigen Express' AE37 HER2 Peptide Vaccine Named to Shortlist for 5th Annual ViE Awards




Antigen Express' lead vaccine, the AE37 HER2/neu synthetic peptide vaccine, has has been named as a nominee for the BEST THERAPEUTIC VACCINE (approved or in development) according to the shortlist published today for the 5th Annual Vaccine Industry Excellence (ViE) Awards. The ViE awards, sponsored by Novartis Vaccines and Diagnostics, were created to recognize the accomplishments and contributions of companies and individuals in the vaccine industry over the previous 12 months.

The full list of nominees in the Best Therapeutic Vaccine category are:

•Advaxis: ADXS-HPV - HPV

•Antigen Express: AE37 - Breast cancer

•BioSante Pharmaceuticals: GVAX

•Galena Biopharma: NeuVax - Breast cancer

•ImmusanT: Nexvax2 - Celiac disease

•Inovio Pharmaceuticals: VGX-3100 - Cervical cancer

The ViE Award nominees are voted on by those in the global vaccine industry and also judged by a panel of representatives from pharma, biotech, academia, government, non-governmental organizations (NGOs), and public health. Winners are announced at the annual ViE Awards dinner and ceremony, taking place this year on April 11 during the World Vaccine Congress in Washington, D.C. Click on AE37 Vaccine to go to the ViE Awards link on the World Vaccine Congress' website.

Bring it home, Antigen Express!